TERM SHEET Between CIPLA TECHNOLOGIES LLC a Delaware limited liability company, having its principal place of business at 12220, El Camino Real, Ste 310, San Diego, CA, 92130, United States of America And PULMATRIX INC. a company duly organized and...Term Sheet • April 1st, 2019 • Pulmatrix, Inc. • Pharmaceutical preparations • Delaware
This binding term sheet (“Term Sheet”) executed on April 1st 2019 (“Effective Date”) outlines the proposal for the establishment of a drug development arrangement between Cipla or its affiliates (hereinafter “Cipla”) and Pulmatrix Inc. (hereinafter the Company for the development and commercialization of its inhaled Itraconazole (“PulmazoleTM”) product (the “Product”), specifically in respect of all indications related to pulmonary applications, throughout the world (the “Territory”); this arrangement and its related processes being collectively referred to as the “Transaction”).
